2-Benzyloxycarbonylamino-3-{2-[(S)-4-(4-guanidino-butyl)-2,5-dioxo-imidazolidin-1-yl]-acetylamino}-propionic acid anion

ID: ALA1160223

PubChem CID: 44296744

Max Phase: Preclinical

Molecular Formula: C21H29N7O7

Molecular Weight: 491.51

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)NCCCC[C@@H]1NC(=O)N(CC(=O)NCC(NC(=O)OCc2ccccc2)C(=O)O)C1=O

Standard InChI:  InChI=1S/C21H29N7O7/c22-19(23)24-9-5-4-8-14-17(30)28(20(33)26-14)11-16(29)25-10-15(18(31)32)27-21(34)35-12-13-6-2-1-3-7-13/h1-3,6-7,14-15H,4-5,8-12H2,(H,25,29)(H,26,33)(H,27,34)(H,31,32)(H4,22,23,24)/t14-,15?/m0/s1

Standard InChI Key:  SHHPVQXJBBYCBN-MLCCFXAWSA-N

Molfile:  

     RDKit          2D

 35 36  0  0  0  0  0  0  0  0999 V2000
    4.5375   -2.2500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1417   -2.9667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9667   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3292   -2.8167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2375   -2.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0750   -2.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4417   -3.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3000   -2.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6417   -3.4250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3292   -2.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3708   -0.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9000   -2.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5042   -3.7167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3375   -0.3875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1125   -0.8292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7000   -2.4417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2750   -3.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1000   -1.8417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6667   -2.4417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7250   -1.4542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.0167   -3.8167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6750   -3.4292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3583   -1.6292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0958   -0.4042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.8125   -3.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3875   -4.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5042   -1.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3625   -2.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1667   -4.9917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1792   -3.9792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7917   -2.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0750   -1.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7667   -4.5667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7500   -5.5750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5542   -5.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  1  0
  5  3  1  0
  6 17  1  0
  7  9  1  0
  8  6  1  0
  9  6  1  0
 10  1  1  0
 11 23  1  0
 12 10  1  0
 13  2  2  0
 14 11  2  0
 15  3  2  0
 16 12  1  0
 17 16  1  0
 18  8  1  0
 19  7  2  0
 20  8  2  0
 21  7  1  0
 22 12  2  0
 23 28  1  0
 24 11  1  0
 25 21  1  0
 26 25  1  0
  5 27  1  1
 28 32  1  0
 29 26  2  0
 30 26  1  0
 31 27  1  0
 32 31  1  0
 33 30  2  0
 34 29  1  0
 35 33  1  0
  5  4  1  0
 34 35  2  0
M  END

Associated Targets(Human)

ITGB3 Tclin Integrin alpha-IIb/beta-3 (3481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB3 Tclin Integrin alpha-V/beta-3 (2708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 491.51Molecular Weight (Monoisotopic): 491.2128AlogP: -0.94#Rotatable Bonds: 13
Polar Surface Area: 216.04Molecular Species: ZWITTERIONHBA: 7HBD: 7
#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 8#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.42CX Basic pKa: 12.17CX LogP: -2.82CX LogD: -2.82
Aromatic Rings: 1Heavy Atoms: 35QED Weighted: 0.08Np Likeness Score: -0.46

References

1. Peyman A, Wehner V, Knolle J, Stilz HU, Breipohl G, Scheunemann KH, Carniato D, Ruxer JM, Gourvest JF, Gadek TR, Bodary S..  (2000)  RGD mimetics containing a central hydantoin scaffold: alpkha(v)beta3 vs alpha(IIb)beta3 selectivity requirements.,  10  (2): [PMID:10673106] [10.1016/s0960-894x(99)00661-7]

Source